Hydroxyl Containing Patents (Class 436/131)
  • Patent number: 7081347
    Abstract: A method for assessing aspirin resistance and relative risk of a cardiovascular event in a patient taking aspirin is provided. The concentration of 11-dehydro-thromboxane B2 in a urine sample is measured and compared to a set of standardized quartile concentrations. A concentration of urinary 11-dehydro-thromboxane B2 that falls within the second, third, or fourth quartile is indicative of aspirin resistance and an elevated risk of a recurrent cardiovascular event.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: July 25, 2006
    Assignee: McMaster University
    Inventors: Salim Yusuf, Jack Hirsh, John Eikelboom
  • Patent number: 7045097
    Abstract: A biologic electrode array is formed on a semiconductor substrate. A matrix of electrode sites is disposed on the semiconductor substrate. A matrix of optical detectors is disposed beneath the electrode sites in the semiconductor substrate, wherein each electrode site is associated with a corresponding optical detector. The optical detectors are coupled to detection circuitry formed on the semiconductor substrate. The electrode sites may include slitted electrodes, punctuated electrodes, or optically transparent electrodes.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: May 16, 2006
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 6867048
    Abstract: A method of addressing and driving an electrode array includes the step of addressing one or more electrodes within the array using a plurality of row and column lines. In one aspect of the method, a value corresponding to a voltage is stored in a local memory associated with each electrode. The addressed electrodes are then driven at the voltages corresponding to the stored values. In another aspect of the method, a driving element associated with each addressed electrode is selectively coupled with a voltage line so as to charge the electrode with the voltage on the voltage line. The device and methods may be used in the synthesis of biopolymers such as oligonucleotides and peptides.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: March 15, 2005
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 6844196
    Abstract: The present invention relates to antioxidant analysis for solder plating solutions, by using a complexing solution comprising a molybdenum compound, such as MoO2Cl2, to form a highly colored antioxidant-molybdenum complex, which can be detected and analyzed by UV-Vis spectroscopic, as a basis for concentration determination for the antioxidant.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: January 18, 2005
    Assignee: Advanced Technology Materials, Inc.
    Inventors: Mackenzie E. King, Cory Schomburg, Monica K. Hilgarth
  • Publication number: 20040096979
    Abstract: The invention relates to a method for the detection and/or measurement of a phenol comprising: (a) contacting the sample to be tested with a polymer imprinted with the phenol or an analogue thereof; and (b) measuring binding of the phenol to the polymer. The polymer may be prepared by polymerising a polymerisable monomer, to which a phenol is covalently bound by a hydrolysable linker, and subsequently removing the phenol by hydrolysis. Propofol is a preferred phenol for use in the invention.
    Type: Application
    Filed: June 25, 2003
    Publication date: May 20, 2004
    Inventors: Miruna Petcu, Janine Cooney, Christian Cook, Denis Richard Lauren
  • Patent number: 6730517
    Abstract: Fully automated modular analytical systems with integrated instrumentation for analysis of biopolymer samples, such as nucleic acids, proteins, peptides and carbohydrates, are provided. Analytical methods of detection and analysis, such as mass spectrometry, radiolabeling, mass tags, chemical tags and fluorescence chemiluminescence, are integrated with robotic technology and automated chemical reaction systems to provide a high-throughput, accurate Automated Process Line (APL).
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: May 4, 2004
    Assignee: Sequenom, Inc.
    Inventors: Hubert Köster, Ping Yip, Jhobe Steadman, Dirk Reuter, Richard MacDonald
  • Patent number: 6727098
    Abstract: A novel achiral biaryl-type compound and a circular dichroism (CD) color fixing agent are provided. Furthermore, a method for determining an absolute configuration of a chiral compound is carried out by introducing the above achiral biaryl-type compound into the chiral compound.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: April 27, 2004
    Assignee: Kanazawa University
    Inventors: Tomihisa Ohta, Shinzo Hosoi
  • Patent number: 6682936
    Abstract: A biologic electrode array assembly is formed on an integrated circuit chip that includes an array of electrodes. At least one metal oxide semiconductor (MOS) switch is coupled to at least one of the electrodes within the array. A voltage line is provided that is selectively connected to the at least one electrode via the MOS switch. A voltage source is coupled to the voltage line. In one preferred aspect of the invention, the MOS switch is a CMOS switch. In another aspect of the invention, an addressable memory is associated with the at least one electrode located within the array.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: January 27, 2004
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Publication number: 20030232444
    Abstract: The present invention relates to an assay for determining the levels of sterols, stanols, steryl esters, fatty acid derivatives and combinations thereof in a starch-containing food product. The assay is particularly useful in supporting product health and/or nutritional claims in manufacturing products intended for human or animal consumption. The present invention describes a method for extracting sterols related compounds and uses as an internal standard a steryl ester, preferably cholesteryl oleate. By using the present extraction technique the process enables the recovery of substantially all of the sterol related compound in the sample.
    Type: Application
    Filed: June 14, 2002
    Publication date: December 18, 2003
    Inventors: Daniel J. Lewandowski, David Plank
  • Publication number: 20030215953
    Abstract: A method of separating cresol from mares' urine by pervaporation using pore-free polymeric silicone membranes in which starting urine solutions containing high-quality and -quantity conjugated estrogens with a reduced or substantially removed cresol content are provided which are advantageously suitable for obtaining natural mixtures of conjugated estrogens from pregnant mares' urine.
    Type: Application
    Filed: March 28, 2003
    Publication date: November 20, 2003
    Applicant: Solvay Pharmaceuticals GmbH
    Inventors: Heinz-Helmer Rasche, Kirsten Wilbrand, Kerstin Woltmann
  • Patent number: 6623974
    Abstract: The invention provides an ozone hydroxy radical analysis method for a liquid carrying a suspension of organic matter. The analyser includes a reactor vessel 2 having sample inlets and outlets 3 and 4 respectively for a liquid stream 5. The reactor vessel 2 is connected to a control system 10 and is fed from an acid vessel 15, a base vessel 16 and an ozone generator 20. The reactor vessel 2 contains glass beads and a catalyst is introduced into the reactor vessel. With a manganese catalyst and glass beads, the manganese coats the glass beads which therefore retain catalyst with the reactor vessel.
    Type: Grant
    Filed: March 23, 2000
    Date of Patent: September 23, 2003
    Assignee: Analytical Developments Limited
    Inventors: Martin Horan, Seamus O'Mahony
  • Patent number: 6608178
    Abstract: Antibody specific for a 5-HTOL compound. A glucuronide with 5-hydroxytryptophol (5-HTOL) characterized in that it comprises the structure of the &bgr;-glucuronide between the 5-hydroxy group of 5-HTOL and D-glucopyranosiduronic acid. An immunoassay and a diagnostic method utilizing the ummunoassay wherein a 5-hydroxytryptophol (5-HTOL) compound is determined by the use of an antibody specific for a 5-HTOL compound is used.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: August 19, 2003
    Assignee: Alco Dia A.B.
    Inventors: Ragnhild Brandt, Olof Beck, Anders Helander, Rose-Marie Jonsson, Eric Unger, Stefan Borg, Eva Akerblom
  • Patent number: 6565810
    Abstract: A method for determining the concentration of a dihydric phenol in the presence of a monohydric phenol uses spectroscopic detection at at least two wavelengths. Because the method does not require a chemical separation of the dihydric phenol and monohydric phenol, it is very rapid and particularly suitable for the analysis of large numbers of samples, such as those derived from combinatorial libraries.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: May 20, 2003
    Assignee: General Electric Company
    Inventors: James Claude Carnahan, Ralph Joseph May
  • Patent number: 6531320
    Abstract: A method of judging the redox (oxidation-reduction) in human blood plasma precisely in a short time using electron spin resonance (ESR) spectroscopy is provided. Also, a method of evaluating the functions of human kidneys, judging whether a dialysis is necessary, determining the dialysis time and judging the usefulness of dialysis materials is offered. First, a spin-trapping agent such as PBN is added to a human blood plasma, resulting in hydroxyl radicals in the plasma. The radicals are trapped and converted into a stable spin adduct (PBN-OH). The amount of the spin adduct is measured by an ESR spectrometer.
    Type: Grant
    Filed: February 3, 1999
    Date of Patent: March 11, 2003
    Inventors: Masahiro Kohno, Shigeru Ohwada
  • Publication number: 20020187075
    Abstract: A hydrogen sensor includes a first electrode 3 and a second electrode 4 provided in contact with a proton conduction layer 2; a gas diffusion controlling portion 6 provided between a measurement gas atmosphere and the first electrode 3; and a support element (1a, 1b) for supporting the proton conduction layer 6, the first electrode 3, the second electrode 4, and the gas diffusion controlling portion 6. Hydrogen contained in a measurement gas introduced via the gas diffusion controlling portion 6 is dissociated, decomposed, or reacted by applying a voltage between the first electrode 3 and the second electrode 4 to thereby generate protons. Hydrogen concentration is obtained on the basis of a limiting current generated as a result of the generated protons being pumped out via the proton conduction layer 2 from the first electrode 3 side of the proton conduction layer to the second electrode 4 side of the proton conduction layer.
    Type: Application
    Filed: April 11, 2002
    Publication date: December 12, 2002
    Applicant: NGK SPARK PLUG CO., LTD.
    Inventors: Norihiko Nadanami, Tomonori Kondo, Masaya Watanabe, Ryuji Inoue, Noboru Ishida, Takafumi Oshima
  • Publication number: 20020131898
    Abstract: An alcohol sensor having gas-sensitive layers made of polymers or inorganic oxides wherein a signal is read out by means of work function change which is produced in the form of a field-effect transistor.
    Type: Application
    Filed: March 4, 2002
    Publication date: September 19, 2002
    Inventors: Maximillian Fleischer, Hans Meixner, Tim Schwebel, Elfriede Simon
  • Patent number: 6426190
    Abstract: A process and a kit are provided for detecting differences in two or more samples of protein, including proteins bearing post-translational modifications and peptides. Proteins are prepared, for example, from each of a different group of cell samples or body fluid samples to be compared. Each protein extract is labeled with a different one of a luminescent dye from a matched set of dyes. The matched dyes have generally the same ionic and pH characteristics but emit light at different wavelengths to exhibit a different color upon luminescence detection. The labeled protein extracts are mixed together and separated together by electrophoresis or a chromatographic method. The separation is observed to detect proteins unique to one sample or present in a greater ratio in one sample than in the other. Those unique or excess proteins will fluoresce the color of one of the dyes used. Proteins common to each sample migrate together and fluoresce the same.
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: July 30, 2002
    Assignee: Carnegie Mellon University
    Inventors: Jonathan Minden, Alan Waggoner, Susan Janet Fowler
  • Patent number: 6406916
    Abstract: A method for determining the concentration of a dihydric phenol in the presence of a monohydric phenol uses spectroscopic detection at at least two wavelengths. Because the method does not require a chemical separation of the dihydric phenol and monohydric phenol, it is very rapid and particularly suitable for the analysis of large numbers of samples, such as those derived from combinatorial libraries.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: June 18, 2002
    Assignee: General Electric Company
    Inventors: James Claude Carnahan, Ralph Joseph May
  • Patent number: 6362006
    Abstract: A method and apparatus for rapid parallel determination of non-volatile analytes in multiple samples is provided. The method utilizes analyte-enhanced fluorescence of a solvatochromic dye, and thus is not dependent on fluorescence of the analyte itself. An evaporation step removes volatile sample components that might otherwise interfere with analyte determination. The method is sensitive to a wide range of analyte concentrations and robust to variations in sample volume.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: March 26, 2002
    Assignee: General Electric Company
    Inventors: Radislav Alexandrovich Potyrailo, John Patrick Lemmon
  • Patent number: 6333199
    Abstract: The method of analyzing polyphenols and bisphenols in accordance with the present invention comprises a step of reacting a bisphenol and/or a polyphenol with a labeling reagent having a pyrene group, so as to generate a fluorescent derivative; a step of irradiating the fluorescent derivative with excitation light and detecting fluorescence emitted from the fluorescent derivative; and a step of calculating an amount of the bisphenol and/or polyphenol in a test sample according to an intensity of thus detected fluorescence and a relationship between a known concentration of a bisphenol and/or a polyphenol contained in a standard sample and fluorescence intensity.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: December 25, 2001
    Assignee: Laboratory of Molecular Biophotonics
    Inventors: Hitoshi Nohta, Hideyuki Yoshida, Masatoshi Yamaguchi
  • Patent number: 6316269
    Abstract: The present invention provides screening methods for identifying compounds which induce tardive dyskinesia (TD) when administered to an animal. In particular, the methods involve assaying for intermediates and end products of reactions associated with candidate compound mediated reduction of reducible substrates. Also provided are high-throughput screening methods for determining whether compounds induce TD when administered to an animal. Further, provided are methods for treating psychoses comprising testing antipsychotic drugs to identify those which will not induce TD when administered to an animal and administering one or more such drugs to a patient in need thereof.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: November 13, 2001
    Assignee: The General Hospital Corporation
    Inventors: Guochuan Tsai, Xudong Huang, Ashley I. Bush
  • Patent number: 6258606
    Abstract: An improved biologic electrode array and methods for manufacturing and using the same. In one aspect, a matrix of electrodes each coupled to a respective sample-and-hold circuit is provided. The electrodes and sample-and-hold circuits are integral and form an array within a single semiconductor chip, such that each sample-and-hold circuit may be loaded with a predefined voltage provided by a single, time-shared digital-to-analog converter (DAC). Further, all of the sample-and-hold circuits may be accessed through a multiplexer which may be scanned through some or all of the electrode locations. Each sample-and-hold circuit may comprise a capacitor and one or more transistor switches, the switch(es), when closed, providing electrical communication between the capacitor and a source line formed in the matrix.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: July 10, 2001
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 6194215
    Abstract: The wetting-agent solution proposed contains of water and at least one organic solvent miscible with water. The speed of sound in the solution is measured and, from the value obtained, a control signal is generated to keep the composition of the solution constant.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: February 27, 2001
    Assignee: Baldwin Grafotec GmbH
    Inventors: Wolfgang Rauh, Stephan Dietzel
  • Patent number: 6156577
    Abstract: A method of measuring an amount of a polyphenol compound in a liquid sample containing at least one polyphenol compound comprises a step of separating the liquid sample into each component, a step of adding at least one reagent capable of specifically reacting with the polyphenol compound to emit light, into the components separated in the separating step, thereby to perform a reaction, and a step of detecting the light emitted by the reaction, wherein the separation in the separating step is conducted by a liquid chromatography and the reagent used for the reaction is the combination of an oxidizing agent of the polyphenol compound, a heme compound and a hydrogen acceptor. A device suitable for performing the above method is also disclosed.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: December 5, 2000
    Assignee: Tohoku Electronic Industrial Co., Ltd.
    Inventors: Teruo Miyazawa, Kiyotaka Nakagawa, Rie Yamada
  • Patent number: 6140099
    Abstract: The invention relates to compositions and methods for delaying the onset of fetal membrane rupture in a human. The method comprises administering to the human a metalloproteinase-9 inhibitor in an amount effective to delay the onset of fetal membrane rupture in the human.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: October 31, 2000
    Assignee: The Trustees of the University of Pennsylvania
    Inventor: Jerome Strauss, III
  • Patent number: 6063637
    Abstract: Sensors (20, 50, 70) for use in detecting the presence of sugars and other analytes (target molecules). The sensor is composed of a metal complex that binds to the target molecule and releases a proton or includes an exchangable ligand which is exchanged for the target molecule during the binding interaction between the metal complex and the target molecule. The result of the binding interaction is the release of a proton, hydroxide ion or ligand species generated during the ligand exchange. Measurement of the release of proton, hydroxide ion or other ligand species from the sensor (20, 50, 70) provides an indirect indication of target molecule concentration. The metal complexes may be attached to support structures (10, 12) to provide both anchoring and positioning of the metal ions to increase selectivity of sugar/metal complex interactions. Detection systems in which pH is used as an indication of proton or hydroxide release are disclosed, as are detection systems in which Cl.sup.- release is used.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: May 16, 2000
    Assignee: California Institute of Technology
    Inventors: Frances H. Arnold, Zhibin Guan, Chao-Tsen Chen, Guohua Chen
  • Patent number: 6054322
    Abstract: A method for the determination of an individual's alcohol consumption, characterized in comprising the steps: i) determining the level of sialic acid in a body fluid sample from the individual; ii) comparing the level found in step (i) with the level for the normal population, an increased level being an indication of an increased alcohol consumption relative to the consumption (per individual) of the normal population.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: April 25, 2000
    Assignee: Axis-Shield ASA
    Inventors: Pekka Sillanaukee, Kaija Seppa, Ola M.ang.rtensson
  • Patent number: 6046054
    Abstract: The selectivity of response of resistive gas sensors to specific gases or vapors is improved by the selection of specified gas-sensitive materials which are not previously known for the applications described, which include detection of hydrocarbons in the presence of CO, H.sub.2 S, SO.sub.2, chlorine, NO.sub.2, CO.sub.2 (especially in low concentrations), CFC's, ammonia, free oxygen by determination of partial pressures, and numerous organic gases and vapors.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: April 4, 2000
    Assignee: Capteur Sensors & Analysers, Ltd.
    Inventors: Peter McGeehin, Patrick Timothy Moseley, David Edward Williams, Geoffrey Stephen Henshaw, Darryl Hirst Dawson, Laura Jane Gellman
  • Patent number: 5981288
    Abstract: The present invention provides for a method and system for determining the concentration of a surfactant in a transparent hydrocarbon by performing the steps of adding a solid to the hydrocarbon; adding a second masking reagent to the hydrocarbon; mixing to form a dispersion; separating the dispersion from the mixture; and measuring the optical absorption of the dispersion.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: November 9, 1999
    Assignee: BetzDearborn Inc.
    Inventors: Wiley L. Parker, Alan E. Goliaszewski, Nancy R. Calvert
  • Patent number: 5965452
    Abstract: An improved biologic electrode array and methods for manufacturing and using the same. In one aspect, a matrix of electrodes each coupled to a respective sample-and-hold circuit is provided. The electrodes and sample-and-hold circuits are integral and form an array within a single semiconductor chip, such that each sample-and-hold circuit may be loaded with a predefined voltage provided by a single, timeshared digital-to-analog converter (DAC). Further, all of the sample-and-hold circuits may be accessed through a multiplexer which may be scanned through some or all of the electrode locations. Each sample-and-hold circuit may comprise a capacitor and one or more transistor switches, the switch(es), when closed, providing electrical communication between the capacitor and a source line formed in the matrix.
    Type: Grant
    Filed: July 9, 1996
    Date of Patent: October 12, 1999
    Assignee: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Patent number: 5958785
    Abstract: Chronic or long-term alcohol consumption is detected and diagnosed by determining the levels of an alcohol-specific ethanol glycoconjugate biomarker, identified as ethyl .beta.-glucuronide, in body fluids (e.g. urine) of subjects by calorimetric reaction using qualitative and quantitative assay methods. Ethyl glucuronide has been newly observed and detected as a direct indicator of chronic alcohol consumption, and can be isolated and purified. Economical and reproducible assay methods, such as a chromatographic spot assay, ascending or thin layer chromatography assay, and high pressure liquid chromatography assay provide reliable, objective, and sensitive methods for detecting and monitoring a chronic alcoholic condition. Both the presence of the alcohol-specific ethyl glucuronide and a substantial increase in its levels are diagnostic of chronic alcoholism.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: September 28, 1999
    Assignee: Research Foundation for Mental Hygiene
    Inventors: Raju K. Pullarkat, Premilia S. Pullarkat, Simhachalam Raguthu
  • Patent number: 5912114
    Abstract: The present invention is directed to the diagnosis and assessment of wound status by quantitating levels of cortisol present in wound fluid. The present invention is also directed to a kit and test strip for assessing wound status.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: June 15, 1999
    Assignee: Johnson & Johnson Medical, Inc.
    Inventors: Tyrone D. Hutchinson, Hansen P. Swaniker
  • Patent number: 5866427
    Abstract: In the method of the invention, in vitro proton MRS is employed to determine the measurable ethanol concentrations in ethanol-treated erythrocyte samples of occasional and heavy drinkers. An erythrocyte to plasma ethanol concentration ratio is determined based upon the MRS measured erythrocyte concentration. Erythrocyte to plasma ethanol concentration ratios are significantly greater for heavy drinkers (a subset of alcohol tolerant individuals) as compared to the ratios calculated for occasional drinkers (non-tolerant individuals) when erythrocyte ethanol concentration is determined by MRS. Thus, the method of the present invention discriminates between alcohol tolerant individuals and alcohol non-tolerant individuals based upon the magnitude of the erythrocyte to plasma ethanol concentration ratio obtained according to the methods disclosed herein.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: February 2, 1999
    Assignee: The McLean Hospital Corporation
    Inventors: Jack H. Mendelson, Nancy K. Mello, Tak-Ming Chiu
  • Patent number: 5851837
    Abstract: A method for making bisphenol salt as the result of the reaction between bisphenol and an alkali metal hydroxide. The method comprising steps to obtain the anhydrous alkali metal bisphenoxide salt within about a 0.2 mol % stoichiometry relationship between bisphenol and alkali metal hydroxide. A method for determining stoichiometry error of a sample comprises determining variables and applying the variables to an equation to determine stoichiometry.
    Type: Grant
    Filed: February 6, 1997
    Date of Patent: December 22, 1998
    Assignee: General Electric Company
    Inventors: Edward Brittain Stokes, Thomas Link Guggenheim, James Marshall Finan
  • Patent number: 5840586
    Abstract: The present invention provides a more accurate risk assessment of antenatal screening results because the maternal age of the patient is considered in evaluating the results from various common screening markers, and especially the results from UE determinations.
    Type: Grant
    Filed: November 30, 1995
    Date of Patent: November 24, 1998
    Assignee: Clinical Diagnostic Systems, Inc.
    Inventor: Christopher John Davies
  • Patent number: 5824559
    Abstract: A method and a device for the analysis of 5-hydroxyindoles or catecholamines with high sensitivity. New chemiluminescence labeling agents, 6-aminomethylphthalhydrazide or 1,2-bis(phthalhydrazino)ethylenediamine, are reacted with 5-hydroxyindoles or catecholamines to form their stable derivatives. The derivatives emit strong luminescence in the presence of an oxidizing agent. In the chemiluminescence detection method, there is extremely low background noise and thus the method enables analysis with high sensitivity.
    Type: Grant
    Filed: June 17, 1996
    Date of Patent: October 20, 1998
    Assignee: Laboratory of Molecular Biophotonics
    Inventors: Hitoshi Nohta, Masatoshi Yamaguchi, Junichi Ishida, Kivoshi Zaitsu, Hiroko Iida
  • Patent number: 5779979
    Abstract: A method and test kit for the detection of hydroxy substituted aromatic compounds using a titanium film (12, 23) which reacts with the compound to change the light absorbance. Preferred films are prepared by reaction of a titanium alkoxide with an aliphatic carboxylic acid. The change in light absorbance of the film is preferably detected with an ultraviolet-visible spectrophotometer. Preferably the film is provided on a transparent slide (22) or on an inside wall of a spectrophotometer cell (10). The cells (10 and 20) are provided with covers (13 and 14) for holding the solution to allow the hydroxy substituted compounds to react with the film.
    Type: Grant
    Filed: August 12, 1996
    Date of Patent: July 14, 1998
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Kris A. Berglund, Joel I. Dulebohn, Beatrice A. Torgerson
  • Patent number: 5776415
    Abstract: A method and test kit for the detection of hydroxy substituted aromatic compounds using a titanium film (12, 23) which reacts with the compound to change the light absorbance. Preferred films are prepared by reaction of a titanium alkoxide with an aliphatic carboxylic acid. The change in light absorbance of the film is preferably detected with an ultraviolet-visible spectrophotometer. Preferably the film is provided on a transparent slide (22) or on an inside wall of a spectrophotometer cell (10). The cells (10 and 20) are provided with covers (13 and 14) for holding the solution to allow the hydroxy substituted compounds to react with the film.
    Type: Grant
    Filed: August 12, 1996
    Date of Patent: July 7, 1998
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Kris A. Berglund, Joel I. Dulebohn, Beatrice A. Torgerson
  • Patent number: 5766952
    Abstract: The present invention relates to a process for indicating the presence of organic vapors comprising the steps of determining the color, absorption or emission spectra of a Pt--Pt double-complex salt of platinum or a neutral platinum complex in the absence of organic vapor, exposing said double-complex salt of platinum or a neutral platinum complex to a gaseous environment, determining the color, absorption or emission spectra of said double-complex salt of platinum or a neutral platinum complex after exposure to said gaseous environment, and comparing the color, absorption and/or emission spectra of said double-complex salt of platinum or a neutral platinum complex in the absence of organic vapor with the color, absorption and/or emission spectra of said double-complex salt of platinum or a neutral platinum complex after exposure to said gaseous environment to determine if there is a difference in the color, absorption and/or emission spectra.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: June 16, 1998
    Assignee: Regents of The University of Minnesota
    Inventors: Kent R. Mann, Charles A. Daws, Christopher L. Exstrom, Daron E. Janzen, Marie Pomije
  • Patent number: 5756631
    Abstract: Viscous, liquid hexafluoroisopropanol-siloxane polymers having the basic structure: ##STR1## wherein R.sub.1 is a monovalent hydrocarbon radical selected from the group consisting of C.sub.1 -C.sub.6 alkyl groups; cyclohexyl groups and phenyl groups;R.sub.2 is ##STR2## wherein m=1 to 4; and n is an integer greater than 1, are useful for rapid, reversible vapor sorption, especially for hydrogen bond accepting vapors.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: May 26, 1998
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: Jay W. Grate
  • Patent number: 5750348
    Abstract: The present invention provides a new method for screening for insulin resistance that utilizes both myoinositol and chiroinositol as indicators. According to this method, levels of myoinositol and D-chiroinositol are measured. The value of the concentration of myoinositol is divided by that of D-chiroinositol to give a "myo/chiro ratio." The value of this ratio is compared with a value that is characteristic of insulin resistance. If the characteristic value is equaled or exceeded, insulin resistance is indicated.
    Type: Grant
    Filed: July 8, 1994
    Date of Patent: May 12, 1998
    Assignee: The University of Virginia Patents Foundation
    Inventor: Joseph Larner
  • Patent number: 5750407
    Abstract: The method described comprises the steps of, firstly, a water content of from 3 to 20 wt %, based on the water-containing fluid, being set in the hydraulic fluid to be tested, followed by the water-containing fluid being mixed with at least 1 part by volume of tetrahydrofuran or monoethylene glycol dimethyl ether per part by volume of water-containing fluid, whereupon the formation or nonformation of a precipitate is ascertained.
    Type: Grant
    Filed: December 12, 1996
    Date of Patent: May 12, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Wilfried Becker
  • Patent number: 5747346
    Abstract: Chronic or long-term alcohol consumption is detected and monitored by determining the level of a newly-observed, alcohol-specific carbohydrate in body fluids (e.g. urine) of subjects by calorimetric reaction using qualitative and quantitative assay methods. The alcohol-specific carbohydrate have been identified as a novel ethyl glucuronide. Ethyl glucuronide is observed and detected in direct response to alcohol consumption in body fluids, and can be isolated and purified. Simple, economical, and reproducible assay methods, such as a spot assay and an ascending or thin layer chromatography assay, provide reliable, objective, and sensitive methods for detecting and monitoring a chronic alcoholic condition. Both the presence of the alcohol-specific ethyl glucuronide and a substantial increase in its levels are indicative of chronic alcoholism.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: May 5, 1998
    Assignee: Research Foundation for Mental Hygiene, Inc.
    Inventors: Raju K. Pullarkat, Premila S. Pullarkat, Simhachalam Raguthu
  • Patent number: 5716850
    Abstract: A method of determining one or both of the colour and bitterness of beer by illuminating the beer with light of a pre-determined wavelength, typically 400.+-.30 nm, to cause iso-.alpha.-acids in the beer to fluoresce. The fluorescence is detected over a range of wavelengths, typically 420 to 673 nm, using a fluorescence spectrophotometer. One or both of the colour and bitterness of the beer is determined by comparing an output signal from the fluorescence spectrophotometer to output signals stored for beers of known colour and bitterness.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: February 10, 1998
    Assignee: Whitbread PLC
    Inventors: Gurinder Takhar, Mandy King
  • Patent number: 5702955
    Abstract: The present invention is a method for the detection of hydrogen peroxide in biological fluids or an aqueous solution which involves contacting the solution with an oxidation-reduction indicator and a transition metal complex. The transition metal complex is either a creatinine coordinated with iron or a guanidine coordinated with iron.
    Type: Grant
    Filed: October 6, 1995
    Date of Patent: December 30, 1997
    Assignee: Bayer Corporation
    Inventor: Michael Pugia
  • Patent number: 5677191
    Abstract: A series of organic test papers are described for the detection and identification of all types of organic compounds such as aldehydes, ketones, esters, acids, amines, isocyanates, anhydrides, amides, nitrides, aromatics, phenols, ethers, and other organic compounds, said test papers comprising an absorbent paper or microporous plastic impregnated with a reagent or reagents capable of reacting with a class of organic compounds. The method of using the test papers for the identification of organic compounds comprises making a presumptive identification of the class of the unknown sample using FTIR spectroscopy, and then placing this presumptively identified sample onto the paper to generate a new substance known as a derivative of the organic compound, which aids in the identification of the unknown organic compound.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: October 14, 1997
    Assignee: Janos Technology Inc.
    Inventor: William L. Truett
  • Patent number: 5635404
    Abstract: Electrospray ionization mass spectroscopy (ESI-MS) methods, tagging reagents and novel compounds for labeling neutral compounds to provide ionized compounds for mass spectroscopy analysis, and novel compounds discovered using such EES-MS methods, including fulleroids
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: June 3, 1997
    Assignee: New York University
    Inventor: Stephen R. Wilson
  • Patent number: 5532166
    Abstract: Capillary Zone Electrophoresis (CZE) with laser-excited fluorescence detection has been found to be a fast, easy, and accurate method for directly measuring serum retinol. Due to its small sample requirements, the method may be used for finger-prick analysis.
    Type: Grant
    Filed: July 27, 1995
    Date of Patent: July 2, 1996
    Inventor: Yinfa Ma
  • Patent number: 5508203
    Abstract: A source of high frequency electromagnetic radiation is coupled to a specimen containing a target chemical whose presence and/or concentration is to be ascertained. Preferably the source radiation includes a plurality of high frequency spectra, at least one of which encourages energy transfer with the chemical of interest. The source radiation is coupled to the specimen via a probe pair that is also used to access a return signal representing an interaction between the source signal and the specimen. The return signal is processed to yield a spectral signature correlating to the target chemical and/or its concentration. Preferably signal processing compares frequency spectra within the source signal to spectra within a sampled return signal. The sampled return signal is a signal obtained by sampling a return signal at the probe pair and by sampling the response to the source signal of a circuit that electrically approximates the specimen.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: April 16, 1996
    Inventors: Milton E. Fuller, Frank J. Cherne
  • Patent number: RE36175
    Abstract: The invention provides a method for determining whether a compound inhibits acetohydroxyacid synthase. The invention further provides a method for determining whether a plant is resistant to an acetohydroxyacid synthase inhibiting compound.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: March 30, 1999
    Assignee: American Cyanamid Company
    Inventor: Dale L. Shaner